TrialDiabetes care2010

Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study.

Petros P Sfikakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.